Researchers at the University of Michigan Comprehensive Cancer Center have developed a new drug that shows potential in laboratory studies against a rare type of acute leukemia. And additional studies suggest the same compound could play a role in prostate cancer treatment as well.
from The Medical News http://ift.tt/1bK2kp3
from The Medical News http://ift.tt/1bK2kp3
No comments:
Post a Comment